Evidence map›Paper›PMID 41234511›Full record

ArticleIEEE transactions on radiation and plasma medical sciences2025

Generative Inpainting-Based Anomaly Detection for CT Liver Tumor Detection.

Yongyi Shi, Chuang Niu, Amber L Simpson, Bruno De Man, Richard Do, Ge Wang

Abstract read
In one paragraph

Article in IEEE transactions on radiation and plasma medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yongyi ShiBiomedical Imaging Center, Department of Biomedical Engineering, School of Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180 USA.
Chuang NiuBiomedical Imaging Center, Department of Biomedical Engineering, School of Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180 USA.
Amber L SimpsonBiomedical Computing and Informatics, Queen's University, ON K7L 3N6, Canada.
Bruno De ManGE HealthCare Technology & Innovation Center, Niskayuna, NY 12309 USA.
Richard DoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA.
Ge WangBiomedical Imaging Center, Department of Biomedical Engineering, School of Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180 USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver MetastasesR01CA233888 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHUN, YUN SHIN, DO, RICHARD KINH GIAN · 2019 to 2023
$3.7M
Adversarially Based Virtual CT Workflow for Evaluation of AI in Medical ImagingR01EB032716 · NIBIB · RENSSELAER POLYTECHNIC INSTITUTE · PI JIA, XUN, MUELLER, KLAUS · 2022 to 2025
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA233888NIBIB NIH HHS R01 EB032716
6 · The paper itself

Abstract

CT is a main modality for imaging liver diseases, valuable in detecting and localizing liver tumors. Traditional anomaly detection methods analyze reconstructed images to identify pathological structures. However, these methods may produce suboptimal results, overlooking subtle differences among various tissue types. To address this challenge, here we employ generative diffusion prior to inpaint the liver as the reference facilitating anomaly detection. Specifically, we use an adaptive threshold to extract a mask of abnormal regions, which are then inpainted using a diffusion prior to calculating an anomaly score based on the discrepancy between the original CT image and the inpainted counterpart. Our methodology has been tested on two liver CT datasets, demonstrating a significant improvement in detection accuracy, with a 7.9% boost in the area under the curve (AUC) compared to the state-of-the-art. This performance gain underscores the potential of our approach to refine the radiological assessment of liver diseases.

Indexed as

anomaly detectionCTdiffusion priorliver tumor

Identifiers

PMID41234511
PMCPMC12610055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.